Related Experiment Videos
Sequestration of amyloid beta-peptide
D Goldgaber1, A I Schwarzman, R Bhasin
1Department of Psychiatry and Behavioral Science, State University of New York, Stony Brook 11794-8101.
Abstract:
Amyloid beta-protein, or beta/A4, is a 4-kilodalton peptide that forms poorly soluble extracellular depositions of amyloid in brains and leptomeninges of patients with Alzheimer's disease (AD), Down's syndrome (DS), and hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). beta/A4 peptide is a derivative of a large transmembrane glycoprotein (APP) and is found in the extracellular space, i.e., in the cerebrospinal fluid and serum of individuals with and without AD and in the conditioned media of many different cells grown in culture. The mechanism by which normally produced amyloid beta peptide forms extracellular aggregates in patients is unknown. One possible explanation is a failure of a mechanism for removal of the beta/A4 peptide that prevents this highly aggregating peptide from forming extracellular amyloid depositions.
Insights
Amyloid beta-protein (Aβ) forms brain amyloid plaques in Alzheimer's disease. A failure in clearing this peptide may cause the harmful extracellular aggregations observed in patients.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Amyloid beta-protein (Aβ) forms extracellular amyloid deposits in Alzheimer's disease (AD), Down's syndrome (DS), and hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D).
- Aβ peptide is derived from the amyloid precursor protein (APP) and is present in cerebrospinal fluid, serum, and cell culture media.
Purpose of the Study:
- To investigate the underlying mechanisms of extracellular amyloid aggregation in neurological disorders.
- To explore potential reasons for the accumulation of amyloid beta-peptide in the brain.
Main Methods:
- Analysis of amyloid beta-protein (Aβ) characteristics.
- Review of existing literature on amyloid formation and clearance.
Main Results:
- Amyloid beta-protein (Aβ) is a peptide known to form poorly soluble extracellular depositions.
- The precise mechanism driving Aβ aggregation in patients remains unclear.
Conclusions:
- A potential explanation for amyloid deposition is a failure in the peptide clearance mechanisms.
- Further research is needed to understand and potentially target Aβ clearance pathways.